A t first glance, psoriasis is a skin disease: Skin symptoms likely led to your diagnosis, and if you’ve dealt with the stigma of psoriasis from others, it was probably because of visible skin lesions ...

Adults with psoriatic arthritis saw early improvements in their symptoms and key health-related quality-of-life measures with ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Psoriasis is a chronic inflammatory immune-cell mediated disease, mediated by cross talk between epidermal keratinocytes, dermal vascular cells, and immunocytes. Psoriatic plaques are well defined and ...

Certain things, like your genes, can increase your risk for psoriatic arthritis. If you have a first-degree relative with psoriatic arthritis, you have 39 times the risk of developing it. Other risks ...

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

Researchers have identified a new potential strategy for inhibiting inflammation in both psoriasis and psoriatic arthritis. The corresponding study was published in the Annals of the Rheumatic ...

Treatment with guselkumab led to improvements in disease activity over 1 year among patients with PsA and showed a high retention rate.

As both a dermatologist and psychologist, I have studied the relationship between mental health and psoriatic disease for years. Many people don’t realize psoriatic disease affects more than just your ...

"Our results are critical, because raising awareness among clinicians about the potential risk of psoriasis in patients with IBD will contribute to systematic ...

The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque psoriasis and active ...

Dr Philip Mease explores how modern imaging tools are reshaping the understanding of joint damage and progression in ...